Possibilities of Influencing Procedural Pain Associated with Premature Newborn Retinopathy Screening with Oral Clonidine
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
HAIE" (CZ.02.1.01/0.0/0.0/16_019/0000798).
European Regional Development Fund under Grant "Healthy Aging in Industrial Environment-HAIE"
PubMed
36360386
PubMed Central
PMC9688525
DOI
10.3390/children9111659
PII: children9111659
Knihovny.cz E-zdroje
- Klíčová slova
- clonidine, oxybuprocaine hydrochloride 0.4%, procedural pain, retinopathy in premature newborns,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: The aim of our study was to compare the analgesic/sedative effects of various fundus-related procedural pain management strategies on the risk of retinopathy in premature infants. METHOD: This was a prospective comparative study involving a total of 94 neonates randomized to three groups meeting the criteria for at-risk neonates. Ophthalmologic screening was performed to evaluate the outcome of three procedural pain management strategies. The intensity of pain over time during and after the screening examination was evaluated. At the same time, we also looked at the occurrence of vegetative symptoms and their influence by the chosen medication. Pain response was observed in all 94 neonates enrolled in the study. In group A, no pain treatment was given. Group B had a local anesthetic oxybuprocaine hydrochloride 0.4% introduced into both eyes immediately prior to the examination. Group C received oral clonidine. The study was conducted as a pilot project and aimed to clarify the problem so that a project with a higher proband representation could take place in the future. Consequently, we performed quantitative analysis of complete pain and vegetative functions, followed by a qualitative analysis of their internal components. RESULTS: In our study, we identified the most considerable effects for all three groups, including NIPS (Neonatal Infant Pain Scale) responses immediately during and after the examination. The influence of vegetative functions is of a longer-term nature and increased values can be clearly demonstrated even six hours after the examination. CONCLUSION: The current results identify and quantify differences among all three methods of pain treatment on the level of single variables. Their internal structures, however, can be analysed only qualitatively because of the small size of the analysed sample.
Zobrazit více v PubMed
Chiswick M.L. Assessment of pain in neonates. Lancet. 2000;355:6–8. doi: 10.1016/S0140-6736(99)00392-X. PubMed DOI
Holsti L., Grunau R.E. Extremity movements help occupational therapists identify stress responses in preterm infants in the neonatal intensive care unit: A systematic review. Can. J. Occup. Ther. 2007;74:183–194. doi: 10.1177/000841740707400306. PubMed DOI
O'Rourke D. The measurement of pain in infants, children, and adolescents: From policy to practice. Phys. Ther. 2004;84:560–570. doi: 10.1093/ptj/84.6.560. PubMed DOI
Carter B.S., Brunkhorst J. Neonatal pain management. Semin. Perinatol. 2017;41:111–116. doi: 10.1053/j.semperi.2016.11.001. PubMed DOI
Ulrich S. Nationella Riktlinjer för Screening och Behandling av Prematuritetsretinopati (ROP) (Reviderade 16 December 2021) 2021. [(accessed on 16 December 2021)]. Available online: https://neo.barnlakarforeningen.se/wp-content/uploads/sites/14/2022/02/Nationella-guidelines-ROP-revidering-16.12.2021.pdf.
Lawrence J., Alcock D., McGrath P., Kay J., MacMurray S.B., Dulberg C. The development of a tool to assess neonatal pain. Neonatal Netw. 1993;12:59–66. doi: 10.1016/0885-3924(91)91127-U. PubMed DOI
Olsson E., Ahl H., Bengtsson K., Vejayaram D.N., Norman E., Bruschettini M., Eriksson M. The use and reporting of neonatal pain scales: A systematic review of randomized trials. Pain. 2020;162:353–360. PubMed PMC
Stevens B., Yamada J., Ohlsson A., Haliburton S., Shorkey A. Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev. 2016;7:Cd001069. doi: 10.1002/14651858.CD001069.pub5. PubMed DOI PMC
McPherson C., Miller S.P., El-Dib M., Massaro A.N., Inder T.E. The influence of pain, agitation, and their management on the immature brain. Pediatr. Res. 2020;88:168–175. doi: 10.1038/s41390-019-0744-6. PubMed DOI PMC
Gunter J.B. Benefit and risks of local anesthetics in infants and children. Paediatr. Drugs. 2002;4:649–672. doi: 10.2165/00128072-200204100-00003. PubMed DOI
Nesargi S.V., Nithyanandam S., Rao S., Nimbalkar S., Bhat S. Topical anesthesia or oral dextrose for the relief of pain in screening for retinopathy of prematurity: A randomized controlled double-blinded trial. J. Trop. Pediatr. 2014;61:20–24. doi: 10.1093/tropej/fmu058. PubMed DOI
Li L., Gao Y., Chen W., Han M. Screening for retinopathy of prematurity in North China. BMC Ophthalmol. 2022;22:251. doi: 10.1186/s12886-022-02470-3. PubMed DOI PMC
Mantz J., Josserand J., Hamada S. Dexmedetomidine: New insights. Eur. J. Anaesthesiol. 2011;28:3–6. doi: 10.1097/EJA.0b013e32833e266d. PubMed DOI
Pichot C., Ghignone M., Quintin L. Dexmedetomidine and clonidine: From second- to first-line sedative agents in the critical care setting? J. Intensive Care Med. 2012;27:219–237. doi: 10.1177/0885066610396815. PubMed DOI
Nguyen V., Tiemann D., Park E., Salehi A. Alpha-2 Agonists. Anesth. Clin. 2017;35:233–245. doi: 10.1016/j.anclin.2017.01.009. PubMed DOI
Janota J. S. Z. Neonatologie. 1st ed. Mlada Fronta; Prague, Czech Republic: 2013.
Zobanova A., Brychcinova P., Autrata R., Senkova K. Screening, Treatment and Long-term Observation of Retinopathy of Prematurely Born Children in the Czech Republic. Česká a A Slov. Oftalmol. 2018;74:253–264.
Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J. Pharmacol. Pharmacother. 2010;340:c332. PubMed PMC
Carlsen Misic M., Eriksson M., Normann E., Pettersson M., Blomqvist Y., Olsson E. Clonidine as analgesia during retinopathy of prematurity screening in preterm infants (cloROP): Protocol for a randomised controlled trial. BMJ Open. 2022;12:e064251. doi: 10.1136/bmjopen-2022-064251. PubMed DOI PMC